Sort   by:  
 Page size 
UnknownTunable Multiscale Nanoparticle Ordering by Polymer Crystallization.
Not available
S-EPMC5532707 | biostudies-literature
UnknownConcurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma.
Not available
S-EPMC11325151 | biostudies-literature
UnknownThe Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study.
Not available
S-EPMC9653309 | biostudies-literature
UnknownIncreased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study.
Not available
S-EPMC9814937 | biostudies-literature
UnknownDevelopment and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).
Not available
S-EPMC7572656 | biostudies-literature
UnknownFunctional Genomics Studies of Psychiatric Disorders in Individuals of Latin American Populations: A Scoping Review.
Not available
S-EPMC12917904 | biostudies-literature
UnknownConcurrent RB1 loss and <i>BRCA</i>-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma.
Not available
S-EPMC10659507 | biostudies-literature
UnknownEfficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.
Not available
S-EPMC8693692 | biostudies-literature
Unknownp53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.
Not available
S-EPMC10073933 | biostudies-literature
UnknownValidated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas.
Not available
S-EPMC9544180 | biostudies-literature
Sort   by:  
 Page size